Medicure Inc
TSXV:MPHView on OTC Pink - Current Information

  • LAST PRICE
    1.0600
  • TODAY'S CHANGE (%)
    -0.1200 (-10.1695%)
  • Bid / Lots
    1.0500/ 23
  • Ask / Lots
    1.1700/ 17
  • Open / Previous Close
    1.0600 / 1.1800
  • Day Range
    1.0600
    1.0600
  • 52 Week Range
    0.9900
    1.8000
  • Volume
    150

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 23, 2024

      Show headlines and story abstract

    • 5:02PM ET on Tuesday Apr 23, 2024 by Dow Jones
      Companies Mentioned: MCUJF, MPH

      WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today that through its subsidiary, Medicure International Inc., the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for MC-1, an investigational product for the prevention or treatment of seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency. Fast Track designation is intended to facilitate the development and expedite the review of drugs that treat serious conditions and fill an unmet medical need.

Peers Headlines